|Articles|July 1, 1997

July 1997
Volume 3
Issue 7

Correspondence regarding, "HMOs and the Efficiency of Healthcare Delivery"

Author(s)James P. Meza, MD, MSA, Author reply by Miron Stano, PhD

Download PDF: Correspondence regarding, "HMOs and the Efficiency of Healthcare Delivery"

Articles in this issue

about 29 years ago

Article

Comparison of Intranasal Triamcinolone Acetonide with Oral Loratadine in the Treatment of Seasonal Ragweed-Induced Allergic Rhinitis

about 29 years ago

Article

Lyme Disease: Recognition, Management, and Prevention in the Primary Care Setting

about 29 years ago

Article

Osteoporosis: Review of Guidelines and Consensus Statements

about 29 years ago

Article

Innovation, One Step at a Time: Same-Day Ileostomy Closure

about 29 years ago

Article

Same-Day Surgery Ileostomy Closure?

about 29 years ago

Article

Managed Care Guidelines for the Economic Evaluation of Pharmaceuticals

about 29 years ago

Article

Pharmacoeconomic Analysis of Selected Antibiotics in Lower Respiratory Tract Infection

about 29 years ago

Article

Clinical Improvement with Bottom-Line Impact: Custom Care Planning for Patients with Acute and Chronic Illnesses in a Managed Care Setting

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Correspondence regarding, "HMOs and the Efficiency of Healthcare Delivery"

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

FDA Advisory Panel Weighs Access to 7 Popular Peptides This Week

Trump Announces Timeline for 100% Generic Drug Tariffs Beginning in 2028, 200% in 2029

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Dermatology Practices Absorb Rising Prior Authorization Costs

Clesrovimab Demonstrates Safety Through a Second RSV Season in High-Risk Infants